Edelweiss MSCI I D W H 45 Index Fund Dir G
Summary Info
Fund Name
: Edelweiss Mutual Fund
Scheme Name
: Edelweiss MSCI I D W H 45 Index Fund Dir G
AMC
: Edelweiss Mutual Fund
Type
: Open
Category
: Equity - Index
Launch Date
: 06-Oct-2020
Fund Manager
: Bhavesh Jain
Net Assets (Rs. cr)
: 199.62
Edelweiss MSCI I D W H 45 Index Fund Dir G - Nav Details
Nav Date
: 09-Oct-2026
NAV [Rs.]
: 24.1134
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Edelweiss MSCI I D W H 45 Index Fund Dir G- NAV Chart
Edelweiss MSCI I D W H 45 Index Fund Dir G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.14 | -2.09 | 0.19 | 14.8 | 15.97 | 18.99 | 13.56 | 15.92 |
| Category Avg | -0.02 | -4.87 | -4.39 | 0.63 | -4.04 | 9.98 | 7.52 | 4.17 |
| Category Best | 3.24 | 6.53 | 5.58 | 28.13 | 33.7 | 33.76 | 18.46 | 25.59 |
| Category Worst | -3.74 | -10.18 | -12.88 | -16.97 | -28.14 | -3.01 | 3.55 | -20.3 |
Edelweiss MSCI I D W H 45 Index Fund Dir G- Latest Dividends
No Records Found
Edelweiss MSCI I D W H 45 Index Fund Dir G- Investment Details
Min. Investment(Rs.)
: 100
Increm.Investment(Rs.)
: 100
In & Out
In
InName Of The CompanyNo Of Shares
Wockhardt5,580
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.45 | 110321 | 20.04 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.09 | 14648 | 13.61 |
| Foreign Equity | ELI LILLY & CO | Pharmaceuticals | 6.46 | 1116 | 12.39 |
| Equity | Apollo Hospitals | Healthcare Services | 5.25 | 12342 | 10.07 |
| Foreign Equity | JOHNSON & JOHNSON | Pharmaceuticals | 4.45 | 3356 | 8.52 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 4.44 | 43046 | 8.52 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.38 | 17489 | 8.39 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 4.34 | 61907 | 8.33 |
| Equity | Max Healthcare | Healthcare Services | 4.19 | 86518 | 8.04 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 3.95 | 61404 | 7.57 |
| Foreign Equity | ABBVIE INC | Biotechnology | 3.22 | 2463 | 6.18 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 2.97 | 28031 | 5.69 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.77 | 31758 | 5.30 |
| Foreign Equity | MERCK & CO.INC | Pharmaceuticals | 2.50 | 3444 | 4.80 |
| Equity | Fortis Health. | Healthcare Services | 2.41 | 60170 | 4.63 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 2.11 | 17301 | 4.03 |
| Foreign Equity | NOVARTIS AG | Pharmaceuticals | 1.82 | 2553 | 3.49 |
| Foreign Equity | THERMO FISHER SCIENTIFIC INC | Life Sciences Tools & Services | 1.75 | 518 | 3.35 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.72 | 17107 | 3.29 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 1.65 | 12659 | 3.16 |
| Foreign Equity | AMGEN INC | Biotechnology | 1.59 | 752 | 3.04 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.47 | 76404 | 2.82 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.38 | 5132 | 2.64 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.37 | 9098 | 2.63 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 1.37 | 22635 | 2.63 |
| Foreign Equity | GILEAD SCIENCES INC | Biotechnology | 1.29 | 1731 | 2.47 |
| Foreign Equity | ABBOTT LABORATORIES | Health Care Equipment & Supplies | 1.20 | 2429 | 2.30 |
| Equity | Aster DM Quality | Healthcare Services | 1.04 | 28589 | 1.99 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.01 | 5362 | 1.94 |
| Foreign Equity | INTUITIVE SURGICAL INC | Health Care Equipment & Supplies | 1.00 | 494 | 1.92 |
| Foreign Equity | DANAHER CORP | Health Care Equipment & Supplies | 0.98 | 888 | 1.88 |
| Foreign Equity | VERTEX PHARMACEUTICALS INC | Biotechnology | 0.93 | 354 | 1.77 |
| Foreign Equity | Novo Nordisk A/S | Pharmaceuticals & Biotechnology | 0.85 | 4490 | 1.63 |
| Foreign Equity | MEDTRONIC PLC | Health Care Equipment & Supplies | 0.77 | 1785 | 1.47 |
| Equity | Global Health | Healthcare Services | 0.70 | 9890 | 1.35 |
| Equity | Narayana Hrudaya | Healthcare Services | 0.70 | 7470 | 1.33 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 0.67 | 4674 | 1.29 |
| Foreign Equity | STRYKER CORP | Health Care Equipment & Supplies | 0.66 | 481 | 1.27 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 0.62 | 5580 | 1.18 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.55 | 12201 | 1.04 |
| Foreign Equity | Regeneron Pharmaceuticals Inc | Pharmaceuticals | 0.55 | 144 | 1.04 |
| Foreign Equity | BECTON DICKINSON & CO | Health Care Equipment & Supplies | 0.34 | 384 | 0.65 |
| Foreign Equity | AGILENT TECHNOLOGIES INC | Life Sciences Tools & Services | 0.34 | 394 | 0.65 |
| Foreign Equity | IQVIA HOLDINGS INC | Life Sciences Tools & Services | 0.31 | 232 | 0.59 |
| Foreign Equity | WATERS CORP | Pharmaceuticals | 0.30 | 137 | 0.57 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Edelweiss Mutual Fund
Incorporation Date:
23-Aug-2007
Total Assets Managed (Cr.):
2,00,980.79
Trustee/s:
Eedelweiss Trusteeship Co
Chairman:
Rujan Panjwani
CEO / MD:
Ms. Radhika Gupta
CIO:
NA
President:
NA
Director/s:
Mr.Bhavesh Jain, Sandeep Bhandarker
Compliance Officer/s:
Mr. Jehzeel Master
Investor Service Officer/s:
Mr. Abdulla Chaudhari
Fund Manager/s:
Bhavesh Jain
Auditors:
NA
OTHER INFORMATION
Registered Office:
Edelwiess House, Off.C.S.T. Road, Kalina, Mumbai - 400 098.
Contact Nos:
022 40979737
Fax:
022 40979878
Email:
Website:
